top of page
Image-empty-state.png

Evelina Tacconelli

Director

Email:

Phone:

+39 045 812 8243

Short biography

Evelina Tacconelli is a Full Professor of Infectious Diseases at the University of Verona, Italy and Head of the DZIF Clinical Research Unit on healthcare associated infections and antimicrobial resistance at the Tübingen University, Germany. She has been Lecturer on Medicine at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA. She was recipient of award from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for research excellence. Consultant for WHO, ECDC and EMA on antimicrobial resistance and infection control. Her main areas of scientific interest are epidemiology, clinical and therapeutic aspects of healthcare-associated infections and preventive measures aimed to reduce the spreading of antibiotic-resistant bacteria. Co-coordinator of the Unit of research on healthcare-associated and antibiotic-resistant bacterial infections (TTU-HAARBI) within the German Center for Infectious Diseases (DZIF). She is the ESCMID Guideline Officer for Infectious Diseases and Clinical Microbiology. Member of the SAB of the JPI-AMR. Chair of the 2018 WHO Priority List of Pathogens for R&D of new antibiotics. Chair of the European Committee of Infection Control (EUCIC). Chair of the ESCMID guidelines on prevention and therapy of infections due to multidrug-resistant Gram negative bacteria (MDR-GN) and EUCIC guideline on decolonization procedures for patients colonized with MDR-GN. Involved (partner site or coordinator) in many European studies on prevention and therapy of infections caused by antibiotic-resistant bacteria financed by European Commission, WHO, JPI-AMR, Horizon2020, DG-Sanco, IMI, and DZIF. She serves on the International Advisory Board of Lancet Infectious Diseases, Editorial Board of Journal of Antimicrobial Chemotherapy and Scientific Committee of Clinical Microbiology and Infection. Author and co-author of more than 200 papers listed in SCI-JCR and NIH Medline. In April 2023 Evelina was appointed as Chief Scientific Officer (CSO) of the Ecraid Foundation.

Projects

ORCHESTRA

PIPELINE

PRIMAVERA

Excellence Centres

ENACT-REACT COVID (MS)

ARCH-NET

ECRAID-Base

VACCELERATE

WHO BPPL

ENACT-SOS COVID

ENACT-REACT COVID (RA)

MPX-RESPONSE

EU-RESPONSE

EPI-Net

SOLIDARITY-Italy

COMBACTE-NET-EXPECT

PROACT EU-Response

AMR Travel Tool

VALUE-DX

Sentinella

ENACT-REACT COVID (LTFU)

Chemsex MSM

Publications

03/01/25

Clinical Infectious Diseases

Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC)

08/12/24

International Journal of Molecular Sciences

Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity

23/12/24

BMC Medicine

Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis

29/11/24

Eurosurveillance

Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies

20/12/24

Genome Medicine

Tracing carriage, acquisition, and transmission of ESBL-producing Escherichia coli over two years in a tertiary care hospital

26/11/24

Scientific Reports

Impact of a two step antimicrobial stewardship program in a paediatric haematology and oncology unit

LOGO IDCARE bianco.png
  • Twitter
  • LinkedIn

Borgo Roma-Policlinico G.B. Rossi, Piazzale Antonio Ludovico Scuro, 10, 37134, Verona, Italy.

Borgo Trento-Ospedale Borgo Trento Piazzale Aristide Stefani, 1 - 37126, Verona, Italy

+39 045 8128243

Copyright © 2024 ID-Care.

bottom of page